Vertex Pharmaceuticals (VRTX) Historical Monthly & Quarterly Returns
Dividend-adjusted returns by month and quarter. Compare performance across years.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.6% | +5.7% | 10.1% | 5.2% | — | — | — | — | — | — | — | — |
| 2025 | +14.6% | +3.9% | +1.0% | +5.1% | 13.2% | +0.7% | +2.6% | 14.4% | +0.2% | +8.7% | +1.9% | +4.6% |
| 2024 | +6.5% | 2.9% | 0.6% | 6.0% | +15.9% | +2.9% | +5.8% | +0.0% | 6.2% | +2.3% | 1.6% | 14.0% |
| 2023 | +11.9% | 10.2% | +8.5% | +8.1% | 5.0% | +8.8% | +0.1% | 1.1% | 0.2% | +4.1% | 2.0% | +14.7% |
| 2022 | +10.7% | 5.4% | +13.5% | +4.7% | 1.7% | +4.9% | 0.5% | +0.5% | +2.8% | +7.8% | +1.4% | 8.7% |
| 2021 | 3.1% | 7.2% | +1.1% | +1.5% | 4.4% | 3.4% | 0.0% | 0.6% | 9.4% | +2.0% | +1.1% | +17.5% |
| 2020 | +3.7% | 1.3% | +6.2% | +5.6% | +14.6% | +0.8% | 6.3% | +2.6% | 2.5% | 23.4% | +9.3% | +3.8% |
| 2019 | +15.2% | 1.1% | 2.5% | 8.1% | 1.7% | +10.4% | 9.1% | +8.0% | 5.9% | +15.4% | +13.4% | 1.3% |
| 2018 | +11.4% | 0.5% | 1.8% | 6.0% | +0.5% | +10.4% | +3.0% | +5.3% | +4.5% | 12.1% | +6.7% | 8.3% |
| 2017 | +16.6% | +5.5% | +20.7% | +8.2% | +4.5% | +4.3% | +17.8% | +5.7% | 5.3% | 3.8% | 1.3% | +3.9% |
| 2016 | 27.9% | 5.8% | 7.0% | +6.1% | +10.4% | 7.7% | +12.8% | 2.6% | 7.7% | 13.0% | +7.6% | 9.7% |
| 2015 | 7.3% | +8.4% | 1.2% | +4.5% | +4.1% | 3.7% | +9.3% | 5.5% | 18.3% | +19.8% | +3.7% | 2.7% |
| 2014 | +6.4% | +2.3% | 12.5% | 4.3% | +6.7% | +31.0% | 6.1% | +5.2% | +20.0% | +0.3% | +4.7% | +0.8% |
| 2013 | +6.9% | +4.6% | +17.4% | +39.7% | +4.6% | 0.3% | 0.3% | 5.8% | +0.9% | 5.9% | 2.7% | +7.0% |
| 2012 | +11.3% | +5.3% | +5.4% | 6.2% | +56.0% | 6.9% | 13.3% | +9.9% | +4.8% | 13.6% | 17.6% | +5.3% |
| 2011 | +11.0% | +20.0% | +2.7% | +14.9% | 1.9% | 3.7% | 0.3% | 12.7% | 1.8% | 11.0% | 26.8% | +14.6% |
| 2010 | 10.4% | +5.6% | +0.8% | 5.1% | 10.8% | 4.9% | +2.3% | 1.0% | +3.8% | +10.8% | 13.5% | +5.7% |
| 2009 | +8.8% | 8.8% | 4.7% | +7.3% | 3.4% | +20.8% | +0.1% | +3.9% | +1.3% | 11.5% | +15.7% | +10.4% |
| 2008 | 12.4% | 14.0% | +36.5% | +6.8% | +12.2% | +16.9% | +3.1% | 22.1% | +23.8% | 21.1% | 6.2% | +23.5% |
| 2007 | 5.5% | 13.2% | 8.6% | +9.6% | 2.7% | 4.5% | +13.1% | +20.6% | 1.4% | 15.8% | 21.5% | 8.5% |
| 2006 | +29.1% | +21.1% | 15.4% | 0.6% | 5.1% | +6.4% | 8.7% | +2.8% | 2.3% | +20.7% | +9.1% | 15.5% |
| 2005 | 3.8% | +13.5% | 18.9% | +1.8% | +46.1% | +21.0% | 5.3% | +15.4% | +21.5% | +1.8% | +12.1% | +8.5% |
| 2004 | 4.3% | +13.7% | 16.4% | 8.3% | +1.9% | +23.2% | 14.9% | +5.4% | +7.9% | +3.6% | 2.4% | 0.5% |
| 2003 | 12.7% | 20.2% | +0.8% | +8.3% | +20.2% | +0.9% | 0.7% | 13.3% | 2.4% | +6.7% | 33.4% | +18.4% |
| 2002 | 19.7% | +10.5% | +27.7% | 23.7% | 7.2% | 17.5% | +21.3% | +0.8% | 7.1% | +6.1% | 5.3% | 14.6% |
| 2001 | 5.9% | 26.1% | 26.4% | +5.3% | +14.0% | +12.7% | 19.3% | 7.7% | 51.1% | +35.8% | +3.3% | 2.8% |
| 2000 | +17.1% | +77.1% | 35.5% | +11.6% | +41.4% | +42.6% | 7.1% | +73.6% | 0.6% | +10.2% | 40.0% | +28.0% |
| 1999 | +5.8% | 25.4% | +7.5% | 16.4% | 5.0% | +20.2% | +4.7% | +9.9% | +11.9% | 7.9% | 7.2% | +31.8% |
| 1998 | +19.0% | 4.8% | 14.6% | 2.6% | 7.6% | 21.8% | 7.2% | 26.9% | +50.7% | +14.7% | 10.2% | +25.7% |
| 1997 | +21.7% | 5.6% | 12.5% | 21.6% | +27.5% | 5.5% | 8.2% | 2.4% | +10.2% | 21.9% | 6.2% | +19.2% |
| 1996 | +1.9% | +2.8% | 4.5% | +10.4% | +27.3% | 18.5% | 18.5% | +28.3% | 7.1% | +12.7% | 3.0% | +24.8% |
| 1995 | +3.3% | +4.9% | 17.0% | +5.6% | +10.5% | +3.9% | +3.1% | +23.0% | 9.6% | 12.0% | +25.0% | +28.5% |
| 1994 | +2.7% | 10.5% | 21.3% | +1.8% | 6.3% | 3.9% | 8.2% | +27.7% | 0.8% | 8.0% | +4.9% | +9.0% |
| 1993 | +2.5% | 25.0% | +6.7% | +3.3% | +39.2% | 17.4% | +2.7% | +2.5% | +27.6% | +17.6% | +6.7% | +15.6% |
| 1992 | 8.5% | 11.1% | 2.0% | +0.0% | 17.0% | 23.2% | +13.3% | +11.8% | +11.8% | 15.3% | +25.1% | 13.3% |
| 1991 | — | — | — | — | — | — | +0.0% | +15.3% | +42.2% | 1.8% | 21.5% | +29.7% |
| Avg | +3.4% | +0.2% | 2.2% | +1.6% | +7.8% | +2.9% | 0.5% | +4.6% | +3.0% | +0.1% | 2.0% | +7.2% |
| Median | +3.7% | 1.1% | 1.8% | +3.3% | +3.0% | +0.9% | 0.0% | +2.6% | 0.2% | +1.8% | 1.3% | +5.7% |
| Win % | 66% | 46% | 43% | 60% | 56% | 56% | 46% | 63% | 49% | 54% | 49% | 66% |
2026
Jan+3.6%
Feb+5.7%
Mar10.1%
Apr5.2%
May—
Jun—
Jul—
Aug—
Sep—
Oct—
Nov—
Dec—
2025
Jan+14.6%
Feb+3.9%
Mar+1.0%
Apr+5.1%
May13.2%
Jun+0.7%
Jul+2.6%
Aug14.4%
Sep+0.2%
Oct+8.7%
Nov+1.9%
Dec+4.6%
2024
Jan+6.5%
Feb2.9%
Mar0.6%
Apr6.0%
May+15.9%
Jun+2.9%
Jul+5.8%
Aug+0.0%
Sep6.2%
Oct+2.3%
Nov1.6%
Dec14.0%
2023
Jan+11.9%
Feb10.2%
Mar+8.5%
Apr+8.1%
May5.0%
Jun+8.8%
Jul+0.1%
Aug1.1%
Sep0.2%
Oct+4.1%
Nov2.0%
Dec+14.7%
2022
Jan+10.7%
Feb5.4%
Mar+13.5%
Apr+4.7%
May1.7%
Jun+4.9%
Jul0.5%
Aug+0.5%
Sep+2.8%
Oct+7.8%
Nov+1.4%
Dec8.7%
2021
Jan3.1%
Feb7.2%
Mar+1.1%
Apr+1.5%
May4.4%
Jun3.4%
Jul0.0%
Aug0.6%
Sep9.4%
Oct+2.0%
Nov+1.1%
Dec+17.5%
2020
Jan+3.7%
Feb1.3%
Mar+6.2%
Apr+5.6%
May+14.6%
Jun+0.8%
Jul6.3%
Aug+2.6%
Sep2.5%
Oct23.4%
Nov+9.3%
Dec+3.8%
2019
Jan+15.2%
Feb1.1%
Mar2.5%
Apr8.1%
May1.7%
Jun+10.4%
Jul9.1%
Aug+8.0%
Sep5.9%
Oct+15.4%
Nov+13.4%
Dec1.3%
2018
Jan+11.4%
Feb0.5%
Mar1.8%
Apr6.0%
May+0.5%
Jun+10.4%
Jul+3.0%
Aug+5.3%
Sep+4.5%
Oct12.1%
Nov+6.7%
Dec8.3%
2017
Jan+16.6%
Feb+5.5%
Mar+20.7%
Apr+8.2%
May+4.5%
Jun+4.3%
Jul+17.8%
Aug+5.7%
Sep5.3%
Oct3.8%
Nov1.3%
Dec+3.9%
2016
Jan27.9%
Feb5.8%
Mar7.0%
Apr+6.1%
May+10.4%
Jun7.7%
Jul+12.8%
Aug2.6%
Sep7.7%
Oct13.0%
Nov+7.6%
Dec9.7%
2015
Jan7.3%
Feb+8.4%
Mar1.2%
Apr+4.5%
May+4.1%
Jun3.7%
Jul+9.3%
Aug5.5%
Sep18.3%
Oct+19.8%
Nov+3.7%
Dec2.7%
2014
Jan+6.4%
Feb+2.3%
Mar12.5%
Apr4.3%
May+6.7%
Jun+31.0%
Jul6.1%
Aug+5.2%
Sep+20.0%
Oct+0.3%
Nov+4.7%
Dec+0.8%
2013
Jan+6.9%
Feb+4.6%
Mar+17.4%
Apr+39.7%
May+4.6%
Jun0.3%
Jul0.3%
Aug5.8%
Sep+0.9%
Oct5.9%
Nov2.7%
Dec+7.0%
2012
Jan+11.3%
Feb+5.3%
Mar+5.4%
Apr6.2%
May+56.0%
Jun6.9%
Jul13.3%
Aug+9.9%
Sep+4.8%
Oct13.6%
Nov17.6%
Dec+5.3%
2011
Jan+11.0%
Feb+20.0%
Mar+2.7%
Apr+14.9%
May1.9%
Jun3.7%
Jul0.3%
Aug12.7%
Sep1.8%
Oct11.0%
Nov26.8%
Dec+14.6%
2010
Jan10.4%
Feb+5.6%
Mar+0.8%
Apr5.1%
May10.8%
Jun4.9%
Jul+2.3%
Aug1.0%
Sep+3.8%
Oct+10.8%
Nov13.5%
Dec+5.7%
2009
Jan+8.8%
Feb8.8%
Mar4.7%
Apr+7.3%
May3.4%
Jun+20.8%
Jul+0.1%
Aug+3.9%
Sep+1.3%
Oct11.5%
Nov+15.7%
Dec+10.4%
2008
Jan12.4%
Feb14.0%
Mar+36.5%
Apr+6.8%
May+12.2%
Jun+16.9%
Jul+3.1%
Aug22.1%
Sep+23.8%
Oct21.1%
Nov6.2%
Dec+23.5%
2007
Jan5.5%
Feb13.2%
Mar8.6%
Apr+9.6%
May2.7%
Jun4.5%
Jul+13.1%
Aug+20.6%
Sep1.4%
Oct15.8%
Nov21.5%
Dec8.5%
2006
Jan+29.1%
Feb+21.1%
Mar15.4%
Apr0.6%
May5.1%
Jun+6.4%
Jul8.7%
Aug+2.8%
Sep2.3%
Oct+20.7%
Nov+9.1%
Dec15.5%
2005
Jan3.8%
Feb+13.5%
Mar18.9%
Apr+1.8%
May+46.1%
Jun+21.0%
Jul5.3%
Aug+15.4%
Sep+21.5%
Oct+1.8%
Nov+12.1%
Dec+8.5%
2004
Jan4.3%
Feb+13.7%
Mar16.4%
Apr8.3%
May+1.9%
Jun+23.2%
Jul14.9%
Aug+5.4%
Sep+7.9%
Oct+3.6%
Nov2.4%
Dec0.5%
2003
Jan12.7%
Feb20.2%
Mar+0.8%
Apr+8.3%
May+20.2%
Jun+0.9%
Jul0.7%
Aug13.3%
Sep2.4%
Oct+6.7%
Nov33.4%
Dec+18.4%
2002
Jan19.7%
Feb+10.5%
Mar+27.7%
Apr23.7%
May7.2%
Jun17.5%
Jul+21.3%
Aug+0.8%
Sep7.1%
Oct+6.1%
Nov5.3%
Dec14.6%
2001
Jan5.9%
Feb26.1%
Mar26.4%
Apr+5.3%
May+14.0%
Jun+12.7%
Jul19.3%
Aug7.7%
Sep51.1%
Oct+35.8%
Nov+3.3%
Dec2.8%
2000
Jan+17.1%
Feb+77.1%
Mar35.5%
Apr+11.6%
May+41.4%
Jun+42.6%
Jul7.1%
Aug+73.6%
Sep0.6%
Oct+10.2%
Nov40.0%
Dec+28.0%
1999
Jan+5.8%
Feb25.4%
Mar+7.5%
Apr16.4%
May5.0%
Jun+20.2%
Jul+4.7%
Aug+9.9%
Sep+11.9%
Oct7.9%
Nov7.2%
Dec+31.8%
1998
Jan+19.0%
Feb4.8%
Mar14.6%
Apr2.6%
May7.6%
Jun21.8%
Jul7.2%
Aug26.9%
Sep+50.7%
Oct+14.7%
Nov10.2%
Dec+25.7%
1997
Jan+21.7%
Feb5.6%
Mar12.5%
Apr21.6%
May+27.5%
Jun5.5%
Jul8.2%
Aug2.4%
Sep+10.2%
Oct21.9%
Nov6.2%
Dec+19.2%
1996
Jan+1.9%
Feb+2.8%
Mar4.5%
Apr+10.4%
May+27.3%
Jun18.5%
Jul18.5%
Aug+28.3%
Sep7.1%
Oct+12.7%
Nov3.0%
Dec+24.8%
1995
Jan+3.3%
Feb+4.9%
Mar17.0%
Apr+5.6%
May+10.5%
Jun+3.9%
Jul+3.1%
Aug+23.0%
Sep9.6%
Oct12.0%
Nov+25.0%
Dec+28.5%
1994
Jan+2.7%
Feb10.5%
Mar21.3%
Apr+1.8%
May6.3%
Jun3.9%
Jul8.2%
Aug+27.7%
Sep0.8%
Oct8.0%
Nov+4.9%
Dec+9.0%
1993
Jan+2.5%
Feb25.0%
Mar+6.7%
Apr+3.3%
May+39.2%
Jun17.4%
Jul+2.7%
Aug+2.5%
Sep+27.6%
Oct+17.6%
Nov+6.7%
Dec+15.6%
1992
Jan8.5%
Feb11.1%
Mar2.0%
Apr+0.0%
May17.0%
Jun23.2%
Jul+13.3%
Aug+11.8%
Sep+11.8%
Oct15.3%
Nov+25.1%
Dec13.3%
1991
Jan—
Feb—
Mar—
Apr—
May—
Jun—
Jul+0.0%
Aug+15.3%
Sep+42.2%
Oct1.8%
Nov21.5%
Dec+29.7%
Avg
Jan+3.4%
Feb+0.2%
Mar2.2%
Apr+1.6%
May+7.8%
Jun+2.9%
Jul0.5%
Aug+4.6%
Sep+3.0%
Oct+0.1%
Nov2.0%
Dec+7.2%
Median
Jan+3.7%
Feb1.1%
Mar1.8%
Apr+3.3%
May+3.0%
Jun+0.9%
Jul0.0%
Aug+2.6%
Sep0.2%
Oct+1.8%
Nov1.3%
Dec+5.7%
Win %
Jan66%
Feb46%
Mar43%
Apr60%
May56%
Jun56%
Jul46%
Aug63%
Sep49%
Oct54%
Nov49%
Dec66%
Frequently asked questions
What is the best performing month for Vertex Pharmaceuticals (VRTX) stock?
- Historically, May is the best performing month for Vertex Pharmaceuticals (VRTX) stock with an average return of +7.78%.
What is the worst performing month for Vertex Pharmaceuticals (VRTX) stock?
- Historically, March is the worst performing month for Vertex Pharmaceuticals (VRTX) stock with an average return of 2.20%.
What is the best performing quarter for Vertex Pharmaceuticals (VRTX) stock?
- Historically, Q2 is the best performing quarter for Vertex Pharmaceuticals (VRTX) stock with an average return of +13.05%.
What is the worst performing quarter for Vertex Pharmaceuticals (VRTX) stock?
- Historically, Q1 is the worst performing quarter for Vertex Pharmaceuticals (VRTX) stock with an average return of +0.60%.
What is the best performing year for Vertex Pharmaceuticals (VRTX) stock?
- Historically, 2000 is the best performing year for Vertex Pharmaceuticals (VRTX) stock with a return of +308.57%.
What is the worst performing year for Vertex Pharmaceuticals (VRTX) stock?
- Historically, 2001 is the worst performing year for Vertex Pharmaceuticals (VRTX) stock with a return of 65.61%.
Which month has the highest win rate for Vertex Pharmaceuticals (VRTX) stock?
- Historically, January has the highest win rate for Vertex Pharmaceuticals (VRTX) stock — positive in 66% of years.
Which month has the lowest win rate for Vertex Pharmaceuticals (VRTX) stock?
- Historically, March has the lowest win rate for Vertex Pharmaceuticals (VRTX) stock — positive in 43% of years.
Which quarter has the highest win rate for Vertex Pharmaceuticals (VRTX) stock?
- Historically, Q2 has the highest win rate for Vertex Pharmaceuticals (VRTX) stock — positive in 69% of years.
Which quarter has the lowest win rate for Vertex Pharmaceuticals (VRTX) stock?
- Historically, Q1 has the lowest win rate for Vertex Pharmaceuticals (VRTX) stock — positive in 46% of years.
Data & methodology
How are returns calculated?
- We compare the closing price at the end of each period (month or quarter) with the closing price at the end of the previous period. The return is the percentage change. All prices are adjusted for dividends and stock splits. Based on historical prices from our data provider.
What is average vs median?
- Average is the arithmetic mean of returns for each period across years. Median is the middle value. Both exclude empty cells. Use median to reduce impact of outliers.
What does the heatmap show?
- Green cells indicate positive returns, red cells indicate negative returns. The darker the color, the stronger the move. Average and Median rows summarize each column across years.
What is Win %?
- Percentage of years when the period had a positive return. For example, 80% for January means January was positive in 80% of the years in the selected range.
Explore more
VRTX Overview
Company profile, financial tools, and key metrics
Explore
VRTX Revenue Counter
Earns $381.74 every second. See per minute, hour, and day.
Explore
VRTX Earnings Counter
Earns $125.36 per second net profit. See per minute, hour, and day.
Explore
VRTX Economic Scale
Exceeds Somalia, Fed. Rep.'s GDP. Compare with world economies.
Explore
VRTX What If Invested
What if you had invested $1,000? See historical returns from any date.
Explore
VRTX How It Makes Money
Discover visual breakdown of $12.04B in revenue — where it comes from and where it goes.
Explore
VRTX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
Explore
VRTX Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
Explore
VRTX Buybacks
1.75% TTM buyback yield. Shareholder yield & SBC comparison.
Explore
VRTX Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
Explore
VRTX Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.
Explore